Antidiabetic activity of angelan isolated from Angelica gigas Nakai

Archives of Pharmacal Research

Volumn 31, Issue 11, 2008, Pages 1489-1496

  Kim, Hwan Mook ^a   Kang, Jong Soon ^a   Park, Song Kyu ^a   Lee, Kiho ^a   Kim, Jee Youn ^b   Kim, Yeon Jin ^b   Hong, Jin Tae ^b   Kim, Youngsoo ^b   Han, Sang Bae ^b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungbuk National University   (South Korea)

Author keywords

Angelan; Angelica gigas Nakai; Autoimmune diabetes; Immunomodulation; Non obese diabetic mice

Indexed keywords

ANGELAN; ANTIDIABETIC AGENT; CYTOKINE; POLYSACCHARIDE;

ANGELICA; ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METABOLISM; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PHENOTYPE; SPLEEN;

ANGELICA; ANIMALS; BLOOD GLUCOSE; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; MICE; MICE, INBRED NOD; MICE, SCID; PHENOTYPE; POLYSACCHARIDES; SPLEEN;

EID: 56749177581     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-2135-9     Document Type: Article

References (29)

1. L. Adorini S. Gregori L. C. Harrison 2002 Understanding autoimmune diabetes: insights from mouse models Trends Mol. Med. 8 31 38
2. M. Bao Y. Yang H. S. Jun J. W. Yoon 2002 Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice J. Immunol. 168 5369 5375
3. G. Dorothee I. Vergnon J. Menez H. Echchakir D. Grunenwald M. Kubin S. Chouaib F. Mami-Chouaib 2002 Tumorinfiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and-mediated cytotoxicity J. Immunol. 169 809 817
4. D. J. Gross H. Sidi L. Weiss T. Kalland E. Rosenmann S. Slavin 1994 Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug Diabetologia 37 1195 1201
5. S. B. Han Y. H. Kim C. W. Lee S. M. Park H. Y. Lee K. S. Ahn I. H. Kim H. M. Kim 1998 Characteristic immunostimulation by angelan isolated from Angelica gigas Nakai Immunopharmacology 40 39 48
6. S. B. Han C. W. Lee M. R. Kang Y. D. Yoon J. S. Kang K. H. Lee W. K. Yoon K. Lee S. K. Park H. M. Kim 2006 Pectic polysaccharide isolated from Angelica gigas Nakai inhibits melanoma cell metastasis and growth by directly preventing cell adhesion and activating host immune functions Cancer Lett. 243 264 273
7. S. B. Han S. H. Park Y. J. Jeon Y. K. Kim H. M. Kim K. H. Yang 2001 Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis J. Pharmacol. Exp. Ther. 299 415 425
8. Y. J. Jeon S. B. Han K. S. Ahn H. M. Kim 1999 Activation of NF-kappaB/Rel in angelan-stimulated macrophages Immunopharmacology 43 1 9
9. Y. J. Jeon S. B. Han K. S. Ahn H. M. Kim 2000 Differential activation of murine macrophages by angelan and LPS Immunopharmacology 49 275 284
10. Y. J. Jeon S. B. Han S. H. Lee H. C. Kim K. S. Ahn H. M. Kim 2001 Activation of mitogen-activated protein kinase pathways by angelan in murine macrophages Int. Immunopharmacol. 1 237 245
11. Y. J. Jeon H. M. Kim 2001 Experimental evidences and signal transduction pathways involved in the activation of NFkappa B/Rel by angelan in murine macrophages Int. Immunopharmacol. 1 1331 1339
12. H. S. Jun P. Santamaria H. W. Lim M. L. Zhang J. W. Yoon 1999 Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ Tcells in T-cell receptor transgenic NOD mice Diabetes 48 34 42
13. H. S. Jun C. S. Yoon L. Zbytnuik N. van Rooijen J. W. Yoon 1999 The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice J. Exp. Med. 189 347 358
14. K. Kida Y. Kaino T. Ito H. Hirai 1998 Controversies on the prevention of insulin-dependent diabetes mellitus by immunomodulation: lessons from NOD mice treated with beta-1,6;1,3-D-glucan and rhIGF-I J. Pediatr. Endocrinol. Metab. 11 Suppl2 327 333
15. K. Kida Y. Kaino T. Ito H. Hirai 1998 Controversies on the prevention of insulin-dependent diabetes mellitus by immunomodulation: lessons from NOD mice treated with beta-1,6;1,3-D-glucan and rhIGF-I J. Pediatr. Endocrinol. Metab. 11 Suppl2 327 333
16. J. Y. Kim Y. D. Yoon J. M. Ahn J. S. Kang S. K. Park K. Lee K. B. Song H. M. Kim S. B. Han 2007 Angelan isolated from Angelica gigas Nakai induces dendritic cell maturation through toll-like receptor 4 Int. Immunopharmacol. 7 78 87
17. J. Liu D. Beller 2002 Aberrant production of IL-12 by macrophages from several autoimmune-prone mouse strains is characterized by intrinsic and unique patterns of NF-kappa B expression and binding to the IL-12 p40 promoter J. Immunol. 169 581 586
18. H. McDevitt 2001 The role of MHC class II molecules in the pathogenesis and prevention of Type I diabetes Adv. Exp. Med. Biol. 490 59 66
19. S. Ramanathan P. Poussier 2001 BB rat lyp mutation and Type 1 diabetes Immunol. Rev. 184 161 171
20. J. G. Rosmalen W. van Ewijk P. J. Leenen 2002 T-cell education in autoimmune diabetes: teachers and students Trends Immunol. 23 40 46
21. T. Rydgren O. Vaarala S. Sandler 2007 Simvastatin protects against multiple low-dose streptozotocin-induced type 1 diabetes in CD-1 mice and recurrence of disease in nonobese diabetic mice J. Pharmacol. Exp. Ther. 323 180 185
22. M. W. Sadelain H. Y. Qin J. Lauzon B. Singh 1990 Prevention of type I diabetes in NOD mice by adjuvant immunotherapy Diabetes 39 583 589
23. B. Salomon D. J. Lenschow L. Rhee N. Ashourian B. Singh A. Sharpe J. A. Bluestone 2000 B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes Immunity 12 431 440
24. J. Satoh S. Shintani K. Oya S. Tanaka T. Nobunaga T. Toyota Y. Goto 1988 Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats Diabetes 37 1188 1194
25. V. Szanya J. Ermann C. Taylor C. Holness C. G. Fathman 2002 The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7 J. Immunol. 169 2461 2465
26. J. Tian D. Zekzer L. Hanssen Y. Lu A. Olcott D. L. Kaufman 2001 Lipopolysaccharide-activated B cells downregulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice J. Immunol. 167 1081 1089
27. T. Toyota J. Satoh K. Oya S. Shintani T. Okano 1986 Streptococcal preparation (OK-432) inhibits development of type I diabetes in NOD mice Diabetes 35 496 499
28. J. W. Yoon H. S. Jun 2001 Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus Ann. N. Y. Acad. Sci. 928 200 211
29. J. W. Yoon C. S. Yoon H. W. Lim Q. Q. Huang Y. Kang K. H. Pyun K. Hirasawa R. S. Sherwin H. S. Jun 1999 Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells Science 284 1183 1187